Log in to save to my catalogue

Pharmacological reversal of synaptic and network pathology in human MECP2‐KO neurons and cortical or...

Pharmacological reversal of synaptic and network pathology in human MECP2‐KO neurons and cortical or...

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_62a5f92686b74314967f1f52b82ce189

Pharmacological reversal of synaptic and network pathology in human MECP2‐KO neurons and cortical organoids

About this item

Full title

Pharmacological reversal of synaptic and network pathology in human MECP2‐KO neurons and cortical organoids

Publisher

London: Nature Publishing Group UK

Journal title

EMBO molecular medicine, 2021-01, Vol.13 (1), p.e12523-n/a

Language

English

Formats

Publication information

Publisher

London: Nature Publishing Group UK

More information

Scope and Contents

Contents

Duplication or deficiency of the X‐linked
MECP2
gene reliably produces profound neurodevelopmental impairment.
MECP2
mutations are almost universally responsible for Rett syndrome (RTT), and particular mutations and cellular mosaicism of
MECP2
may underlie the spectrum of RTT symptomatic severity. No clinically approved treatments...

Alternative Titles

Full title

Pharmacological reversal of synaptic and network pathology in human MECP2‐KO neurons and cortical organoids

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_doaj_primary_oai_doaj_org_article_62a5f92686b74314967f1f52b82ce189

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_62a5f92686b74314967f1f52b82ce189

Other Identifiers

ISSN

1757-4676

E-ISSN

1757-4684

DOI

10.15252/emmm.202012523

How to access this item